Back

Introduction: changing paradigms in LDL-c reduction.

26 August 2022 (12:45 - 12:55)
Organised by:
Congress Presentation Part of: A decade of innovation, guidelines and paradigm shifts in LDL-C management (10th annual symposium) Lipid-Lowering Agents Open Access ESC Congress 2022

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
LDC-c: new insights into its role as causal risk factor and target for therapy
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Targeting the PCSK9 pathway: where do novel therapies fit in?
Associate Professor A. Navar (Dallas, US)
Slides Video
Presentation thumbnail
Addressing the unmet needs in LDL-c lowering: what can we expect?
Professor J. Kastelein (Amsterdam, NL)
Slides Video
Presentation thumbnail
Discussion.
Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
A decade of innovation, guidelines and paradigm shifts in LDL-C management (10th annual symposium)
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 12:45 CET
You may be interested in
thumbnail
Congress Session
The LDL-c challenge in patients with high cardiovascular risk: integrating innovative therapies in clinical management
25 August 2023
thumbnail
Congress Presentation
The remaining challenges in lowering LDL-c in patients at increased CV risk
1 September 2024
thumbnail
Congress Presentation
Introduction.
28 August 2022
thumbnail
Congress Session
Change of paradigm in dyslipidemia management
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources